The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Positive momentum so far this year. Multi million pound long term contract secured in November for operation/maintenance at Triton Knoll wind farm. Energy division looks to be doing particularly well. Also, institutional investor, Odyssean Investment Trust, increased holdings by 1.75% recently. Final results/trading update ought to make interesting reading.
Henry - It's an illiquid stock, tightly held, so I'd not read a lot into daily share price fluctuations. Preliminary results due 9 March. Company looks to be progressing nicely, hopefully we'll know more then.
Thunder - an excellent summary with which I agree entirely. Recent institutional investors, Odyssean and Aberforth Partners add more weight to the argument.
Bermuda - well spotted. Many thanks for the link. Redx remains a most interesting UK biotech play.
No problems getting placing away. Strongly supported and a new specialist investor on board plus director participation.
Well found, Bermuda. Progress continuing nicely.
Positive news again. I'm sure any future fund raise would be well supported due to the exciting pipeline.
The old adage ' you can always buy FOG lower' still applies. Surprised anyone could shift a million shares in this stock Cheddar? Couldn't get a live quote in London to sell ten thousand! This stock has been a portfolio wrecker for all of us during the last decade and beyond.
Agree. Fine end to the year. Thanks for link to clinical trial, Bermuda.
Yes, company is progressing very well indeed.
Another high profile signing by Redx - Dr Jane Griffiths, ex Johnson & Johnson, as Non Executive Chair.
Another high profile signing by Redx - Dr Jane Griffiths, ex Johnson & Johnson, as Non Executive Chair.
Results from second module in Phase 1 Study testing RXC004 in combination with nivolumab are expected this quarter. News possibly imminent, hence price ticking up?
Price ticking up in advance of presentations. Should be an interesting afternoon.
The appointment of Camarco confirms this. They are a highly regarded communications consultancy in the City with high profile clients. Smart move by Falcon as this should bring the company to a wider audience.
Good to see price and volumes remaining strong in advance of Monday's ESMO Congress presentation on RXC004. Exciting times ahead, hopefully.